Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

28th Psychiatric Pharmacotherapy Update 2016 • for CME, CNE, APA, Counseling and Social Work credit


The University of Texas College of Pharmacy welcomes you to the 2016 Psychiatric Pharmacotherapy Update CE event, in Austin, Texas on October 27-28. The Psychiatric Pharmacotherapy Update traditionally provides 15 hours of CEU's on current treads in mental illness treatment for pharmacists, physicians, psychiatrists, psychologists, advance practice nurses, counselors, and social workers.

Hotel Reservations:  See Location website here for more information

Date: Oct 27, 2016 07:45 AM - Oct 28, 2016 04:00 PM

Fee

$425.00

CE Hours

15.00

CE Units

1.500

Registration closes on Oct 28, 2016 09:00 AM

Activity Type

  • Knowledge

Target Audience(s)

  • Physicians
  • Psychologists
  • Psychiatrists
  • Nurses
  • Social Workers

Requirements for CE Credit

Continuing Medical Education:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Texas Medical Association (TMA) through the joint providership of the Texas Department of State Health Services and The University of Texas at Austin College of Pharmacy. The Texas Department of State Health Services is accredited by TMA to provide continuing medical education for physicians.

Continuing Medical Education:
The Texas Department of State Health Services is accredited by the Texas Medical Association to provide continuing medical education for physicians. The Texas Department of State Health Services, Continuing Education Service (TMA provider #4006803) designates this live activity for a maximum of 15 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. This event has been approved by the Texas Department of State Health Services, Continuing Education Service for 4 credits in medical ethics and/or professional responsibility.


Continuing Nursing Education:
The Texas Department of State Health Services, Continuing Education Service is an accredited provider (P0180) of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.  The Texas Department of State Health Services, Continuing Education Service has awarded 15 contact hour(s) of Continuing Nursing Education.


Social Work CEUs:
The Texas Department of State Health Services, Continuing Education Service under sponsor number (CS3065) expiration date of December 31, 2015, has been approved by the Texas State Board of Social Worker Examiners (1-800-232-3162) to offer continuing education contact hours to social workers.  The Texas Department of State Health Services, Continuing Education Service has awarded 15 contact hours of Continuing Social Work Education.


Psychologist:

American Society for the Advancement of Pharmacotherapy (ASAP) is approved by the American Psychological Association to sponsor continuing education for psychologists. ASAP maintains responsibility for this program and its content. This conference is accredited for 15 hours of CEU.



 

 

 

Registration closes on Oct 28, 2016 at 09:00 AM

Registration Closed  

Objectives

  • Discuss current trends in the treatment of Alzheimer’s disease and other dementia disorders
  • Discuss impact of substance abuse in relation to dementia disorders

Speaker(s)/Author(s)

Jason E. Schillerstrom, MD picture

Jason E. Schillerstrom, MD
Associate Professor, Department of Psychiatry, University of Texas Health Science Center San Anto

Date: 10/27/16
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe the pathophysiology and the challenges associate with diagnosis of epileptic seizures.
  • Identify new treatment options available for the management of epilepsy.

Speaker(s)/Author(s)

Collin Hovinga, Pharm.D., M.S., FCCP picture

Collin Hovinga, Pharm.D., M.S., FCCP
Director of Research Clinical Associate Professor, The University of Texas at Austin College of Pharm


Disclosure : Dr. Hovinga has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.
Date: 10/27/16
Time: 09:00 AM - 10:00 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Define the problem of agitation in emergency psychiatry.
  • Identify the unique legal and ethical issues involved in the psychiatric management of agitation.
  • Discuss the pharmacological options for treatment of acute agitation in an emergency department.

Speaker(s)/Author(s)

Keith S. Garcia, MD, PhD picture

Keith S. Garcia, MD, PhD
Associate Professor in Psychiatry, University of Texas at Austin Dell Medical School


Disclosure : Dr. Garcia has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.
Date: 10/27/16
Time: 10:15 AM - 11:15 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe current and advanced process of detection of prescription drug abuse with patients.
  • Discuss current trends in intervention and treatment with patients who have been detected in abusing prescription drug abuse.
  • Discuss ethical dilemmas practitioners face when dealing with a patient who is abusing prescription drugs.

Speaker(s)/Author(s)

Kimberly Arlinghaus, MD picture

Kimberly Arlinghaus, MD
Medical Director of Psychiatry and Behavioral Health, Lone Star Circle of Care


Disclosure : Dr. Arlinghaus has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.
Date: 10/27/16
Time: 11:15 AM - 12:15 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Discuss naloxone pharmacology, produce availability, and device delivery.
  • Discuss the epidemiology of opiate overdose and naloxone therapy outcomes.
  • Discuss ethical and treatment issues with naloxone therapy, availability and outreach.

Speaker(s)/Author(s)

Nile J. Barnes. Pharm.D. picture

Nile J. Barnes. Pharm.D.
Alumni Centennial Endowed Fellow in Pharmacy Clinical Assistant Professor of Health Outcomes & Pharmacy Practice, The University of Texas at Austin College of Pharm


Disclosure : Dr. Barnes is a Team Leader for the UT Austin program Operation Naloxine.org – which solicits and receives donations from Kaleo and Adapt for the Texas Overdose Naloxine Initiative (TONI).
Date: 10/27/16
Time: 01:00 PM - 02:00 PM

CE Hours

1.25
Registration Closed  

Registration Closed  

Objectives

  • Identify the differential diagnosis of attention problems from childhood to adulthood
  • Discuss how to use both pharmacological and psychosocial interventions in adult ADHD.

Speaker(s)/Author(s)

Ali Abbas Asghar-Ali, M.D. picture

Ali Abbas Asghar-Ali, M.D.
Associate Professor, Baylor College of Medicine & DeBakey VA Medical Ce


Brief Bio : Associate Director for Education, South Central MIRECC Director of Geriatric Psychiatry Fellowship Associate Professor, Baylor College of Medicine Geriatric Psychiatrist, Michael E. DeBakey VA Medical Center
Disclosure : Dr. Ali Abbas Asghar-Ali has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.
Date: 10/27/16
Time: 02:15 PM - 03:15 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe the pharmacology, adverse effects, drug interactions, therapeutic uses, and dosing of selected psychiatric drugs recently marketed as well as drugs approaching the market.
  • Review pharmacology, adverse effects, drug interactions, therapeutic uses, and dosing of selected psychiatric drugs that have been released in the past five years.

Speaker(s)/Author(s)

Stephen R. Saklad picture

Stephen R. Saklad, Pharm.D., BCPP
Clinical Associate Professor, UT Austin College of Pharmacy / Director, Psychiatric Pharmacy Program, UT Health Science Center San Antonio , UT Austin College of Pharmacy


Disclosure : Financial Disclosure: consultant or advisory role with Eli Lilly and Ortho McNeil Janssen; on the speaker’s bureau for Janssen, Merck, and Novartis; investigator Ortho McNeil Janssen
Date: 10/27/16
Time: 03:30 PM - 05:00 PM

CE Hours

1.50
Registration Closed  

Registration closes on Oct 28, 2016 at 09:00 AM

Registration Closed  

Objectives

  • Recognize current trends of prescription medication abuse with emphasis on non-scheduled prescription medications.
  • Explain rationales and methodologies of prescription medication abuse.
  • Describe best practice methods for working with patients and prescribers to detect suspected substance use disorders and deter prescription drug diversion.

Speaker(s)/Author(s)

Michael O’Neil, Pharm.D. picture

Michael O’Neil, Pharm.D.
Professor and Chair Department of Pharmacy Practice Drug Diversion, Substance Abuse, and Pain Management, South College School of Pharmacy


Disclosure : Dr. O’Neil has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.
Date: 10/28/16
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Discuss the scale of the issues caused by metabolic disorders.
  • Describe the implication of metabolic disorders as they relate to the morbidity and mortality of patients.
  • Describe what actions can be taken to mitigate these metabolic risks.

Speaker(s)/Author(s)

R. Lowell McRoberts, M.D.  picture

R. Lowell McRoberts, M.D.
Assistant Professor of Psychiatry Department of Psychiatry, The University of Texas Dell Medical School


Disclosure : Dr. McRoberts has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.
Date: 10/28/16
Time: 09:00 AM - 10:00 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Discuss new treatment strategies in the treatment of bipolar disorder.
  • Identify changes in treatment trends over the past five years.
  • Discuss benefits of an inter professional approach in the treatment of bipolar disorders.

Speaker(s)/Author(s)

Stephen Strakowski, M.D.  picture

Stephen Strakowski, M.D.
Chair of Psychiatry, The University of Texas Dell Medical School


Disclosure : Dr. Starkowski has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose: Consultant: Chair of DSMB’s for Sunovion, human resources consultant for Procter & Gamble
Date: 10/28/16
Time: 10:15 AM - 11:15 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Discuss trends in use of synthetic cannabis.
  • Discuss trends in use of synthetic drug such as bath salts in the general population.
  • Discuss benefits of an inter professional approach in the treatment of bipolar disorders.

Speaker(s)/Author(s)

Carlos Tirado, M.D., M.P.H., F.A.B.A.M picture

Carlos Tirado, M.D., M.P.H., F.A.B.A.M
Founder and Owner, ABRI Integrated Health


Disclosure : Dr. Tirado has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose: Speakers Bureau: Indivior & Alkermes Consultant: US WorldMeds as a Medical Monitor
Date: 10/28/16
Time: 11:15 AM - 12:15 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Discuss the connection between microbiome and brain function
  • Review research connection microbiome-gut brain axis and specific mental health disorders of depression, anxiety and autism.
  • Discuss the interactions between the microbiome-gut brain axis and common psychiatric medications.

Speaker(s)/Author(s)

Ruth Ann Luna, Ph.D., MB(ASCP)CM picture

Ruth Ann Luna, Ph.D., MB(ASCP)CM
Assistant Professor, Baylor College of Medicine , Texas Children’s Microbiome Center, Texas Children


Disclosure : Dr. Luna has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.
Date: 10/28/16
Time: 12:30 PM - 01:45 PM

CE Hours

1.25
Registration Closed  

Registration Closed  

Objectives

  • Diagnose borderline personality disorder (BPD) according to the new DSM-5 Alternative Model for Personal Disorders.
  • Discuss the longitudinal course of BPD.
  • Discuss the latest evidence-based recommendations for the treatment of patients with BPD.

Speaker(s)/Author(s)

John M. Oldham, M.D., M.S. picture

John M. Oldham, M.D., M.S.
Professor Barbara & Corbin Robertson, Jr. Endowed Chair for Personality Disorders Menninger Department of Psychiatry and Behavioral Sciences, Baylor School of Medicine


Disclosure : Dr. Oldham has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.
Date: 10/28/16
Time: 02:00 PM - 03:00 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe the new atypical antipsychotics available in the US.
  • Describe new evidence in treating first episode schizophrenia.
  • Describe new evidence supporting augmentation strategies in treatment-resistant schizophrenia.

Speaker(s)/Author(s)

Troy Moore PharmD, MS Pharm, BCPP picture

Troy Moore PharmD, MS Pharm, BCPP
Clinical Pharmacy Specialist – Psychiatry Director, ASHP-Accredited PGY-2 Psychiatric Pharmacy Residency Program Co-Director, Interprofessional Advanced Fellowship in Addiction Treatment, South Texas Veterans Health Care System


Disclosure : Financial Disclosure: no relevant financial relationships to disclose
Date: 10/28/16
Time: 03:00 PM - 03:50 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Date: 10/28/16
Time: 12:00 PM - 12:15 PM
Registration Closed